Skip to main content
. 2018 Nov 6;7(1):13–23. doi: 10.1093/gastro/goy038

Table 3.

Overall results of 21 cases of AP associated with propofol administration

Author, year Country Age, yrs Sex Propofol
Latency Treatment of AP Follow-up Outcome Naranjo scale
Indication Duration Total dose, mg
Leisure et al., 1996 [1] USA 34 Male Induction of anesthesia 65 min 200 24 h Supportive NR Recovery 5 (probable)
43 Male Induction of anesthesia NR NRa few d Supportive NR Recovery 5 (probable)
77 Female Induction of anesthesia NR 100 1–2 d Artificial ventilation Death Death 4 (possible)
58 Female Induction of anesthesia NR 150 1–2 d Hemodialysis Death Death 4 (possible)
Metkus et al., 1996 [22] USA 34 Female Sedation 69 d NRb 69 d Drainage of fluid 330 d Recovery 5 (probable)
Fujii et al., 1998 [23] Japan 73 Male Induction of anesthesia 140 min 100 1 d Supportive NR Recovery 5 (probable)
Şentürk and Kerman, 1999 [24] Turkey 60 Male Induction of anesthesia 140 min 200 2 d Supportive 10 d Recovery 5 (probable)
Bird and Brim, 2000 [25] UK 34 Male Induction of anesthesia 15 min 200 1 d Supportive 7 d Recovery 5 (probable)
Betrosian et al., 2001[26] Denmark 35 Male Induction + maintenance 15 min 140 few h Hemodialysis 21 d Recovery 7 (probable)
Jawaid et al., 2002 [20] USA 21 Female Induction of anesthesia 138 min 150 1 d Supportive- antibiotics 21 d Recovery 7 (probable)
Farina Castro et al., 2002 [27] Spain 23 Male Sedation 7 d 103 750 6 d Supportive 35 d Recovery 5 (probable)
Manfredi et al., 2004 [21] Italy 27 Female Sedation 60 h 600 3 d Supportive-octreotide 19 d Recovery 7 (probable)
Gottschling et al., 2005 [28] Germany 12 Female Sedation 45 min 235 2 h Intensive care NR Recovery 5 (probable)
Rake et al., 2006 [29] USA 12 Male Sedation <24 h NR <24 h Parenteral nutrition NR Recovery 5 (probable)
Coleman et al., 2006 [16] USA 42 Female Induction of anesthesia NR 300 1–2 d Supportive > 18 d Recovery 5 (probable)
Gottesman et al., 2007 [30] USA 36 Female Sedation NR NR 1 d Supportive 14 d Recovery 7 (probable)
Tan et al., 2007 [31] USA 4 Female Induction + maintenance 60 min >45c 10 h Parenteral nutrition 30 d Recovery 5 (probable)
Ting and Lee, 2012 [32] Singapore 14 Female Sedation 2 d 5043 72 h Supportive Death Deathd 5 (probable)
Muniraj and Aslanian, 2012 [33] USA 71 Male Sedation 6 d 8800 5 d Supportive 17 d Recovery 7 (probable)
Scholten and Buijs, 2014 [3] Netherlands 72 Male Anesthesia maintenance few h 300 2–3 h Supportive 365 d Recovery 7 (probable)
Csomor et al., 2017 [34] Czech Republic 57 Female Induction + maintenance NR 250 15 h Artificial ventilation, vasopressors, 14 operations Death Death 6 (probable)
Total: 21 patients 11 countries Median35 yrs 10 males 11 females Sedation: 8 Anesthesia: 13 Median 140 min Median 200 mg Intermediate: 14 20 d Death: 4 Possible: 2 Probable: 19

AP, acute pancreatitis; NR, not reported; min, minute; h, hour; d, day; yrs, years.

aThe reported dose was 1–1.5 mg/kg without reporting the weight and the duration.

bThe reported dose was 30–140 µg/kg/min for 69 days without reporting patient weight.

cThe total dose was 45 mg for induction and not mentioned for maintenance of anesthesia.

dPatient had viral pneumonia, bacterial tracheitis and septic shock before sedation with propofol and died from bronchopneumonia 12 days after the onset of mild AP onset.